Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Investors: Take Advantage of Double Fed Tax Credits on Critical Minerals Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medicenna Therapeutics Ord Shs
T.MDNA
Alternate Symbol(s):
MDNAF
Healthcare
Biotechnology
Medicenna Therapeutics Corp. is a Canada-based clinical-stage immunotherapy company. The Company is focused on the development of selective versions of interleukin-2 (IL-2), interleukin-4 (IL-4) and interleukin-13 (IL-13) Superkines and Empowered Superkines for the treatment of cancer, inflammation and immune-mediated diseases. Its long-acting IL-2 Superkine, MDNA11, is an IL-2 with superior...
CD122 (IL-2 receptor beta) binding without CD25 (IL-2 receptor alpha) affinity, thereby preferentially stimulating cancer-killing effector T cells and NK cells. The Company’s IL-4 Empowered Superkine, bizaxofusp, has been studied in five clinical trials including a Phase IIb trial for recurrent glioblastoma (GBM). The Company’s early-stage Bifunctional SuperKine ImmunoTherapies (BiSKITs) program is designed to enhance the ability of Superkines to treat immunologically cold tumors.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MDNA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
•••
Jon Brown
X
Post by
Jon Brown
on Dec 01, 2023 4:11pm
@ the Bell: December kicks off on a high note
Canada’s main stock index took off on Friday, with industrials leading the charge, followed by metals. Chinese data boosted the mining market.
read article.
•••
Jon Brown
X
Post by
Jon Brown
on Nov 30, 2023 4:21pm
@ the Bell: Markets wrap a November to remember
Canada’s main stock index saw upward movement Thursday as crude oil prices fell, and the TSX tried to snap a four-month losing streak.
read article.
•••
Jon Brown
X
Post by
Jon Brown
on Nov 30, 2023 5:15am
Buzz on the Bullboards: Has the November rally paid off?
In the past week, the energy sector has been leading downward pressure on Canada’s main stock index as crude oil prices continued to fall.
read article.
(217)
•••
Galaxym31
X
Post by
Galaxym31
on Nov 19, 2023 4:22pm
There must be many people in the world that would welcome
a chance to manage this terminal disease not sure why big money has not stepped up to speed up this next trial . Rich people of all ages get this disease . Do it now get involved .
(217)
•••
Galaxym31
X
Post by
Galaxym31
on Nov 19, 2023 3:29pm
Why only a single treatment for GBM .
..
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 17, 2023 7:00am
New Press Release - Medicenna Announces Compelling Survival Benefit from Phase 2b Study of Bizaxofusp in Recurrent Glioblastoma at the 28th Annual Meeting of the Society for NeuroOncology
Single treatment of bizaxofusp doubled mOS (14.5 months vs. 7.2 months) irrespective of IL4R expression (high or low) compared to patients treated in the external control arm Survival for bizaxofusp-treated patients increased 370% at Year 1 and increased more than 50% at Year 2TORONTO and...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 14, 2023 8:30am
New Press Release - Medicenna Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Operational Highlights
Cash runway extended through multiple data readouts and into Q1 of calendar 2025 MDNA11 is generally well tolerated and continues to demonstrate encouraging single-agent activity from Phase 1 portion of the ABILITY-1 Study including 100% and 70% reduction of target lesions in pancreatic and...
read article.
(40)
•••
cueball40
X
Post by
cueball40
on Nov 10, 2023 10:36am
its trading nicely
looks like too me we heading much much higher ... could be a 5 bagger soon added more .55
...more
(217)
•••
Galaxym31
X
Post by
Galaxym31
on Nov 09, 2023 9:12pm
I do not think they would make this presentation if all the
patients had died say at 18 months .Bring on the new trials . Kill GBM .
(217)
•••
Galaxym31
X
Post by
Galaxym31
on Nov 09, 2023 10:59am
Go ahead buy a million shares cheap cheap .
Do it .
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 09, 2023 8:57am
New Press Release - Medicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp Survival Data in Recurrent Glioblastoma at the Society for Neuro-Oncology 2023 Annual Meeting
TORONTO and HOUSTON, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTC: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, today announced that a poster presentation and an oral summary highlighting...
read article.
(217)
•••
Galaxym31
X
Post by
Galaxym31
on Nov 07, 2023 8:48pm
Could be taken out .
.
(15)
•••
bigkagan
X
Comment by
bigkagan
on Nov 07, 2023 5:17pm
RE:RE:RE:Very low market cap .
That's right. How often do you hear that a cancer drug manages to shrink or eliminate a tumor like the one that MDNA has. Most cancer drugs get approved if they prolong life by 6 months, never
...more
(217)
•••
Galaxym31
X
Comment by
Galaxym31
on Nov 06, 2023 4:08pm
RE:RE:Very low market cap .
6.00 on the way to 20.00 IMO . US of course .
(147)
•••
windymayor1
X
Comment by
windymayor1
on Nov 06, 2023 10:26am
RE:Very low market cap .
bloom burton $6.00 US target
(217)
•••
Galaxym31
X
Post by
Galaxym31
on Nov 03, 2023 1:47pm
Very low market cap .
IMO
(147)
•••
windymayor1
X
Post by
windymayor1
on Nov 02, 2023 8:50pm
Value
Currently trading under cash value.
(17)
•••
whytestocks
X
Post by
whytestocks
on Sep 06, 2023 10:30pm
Medicenna to Participate at The H.C. Wainwright 25th Annual
Just In: $MDNA Medicenna to Participate at The H.C. Wainwright 25th Annual Global Investment Conference | BenzingaTORONTO and HOUSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
AI Alchemy: Turning Data into Gold with Artificial Intelligence
Gander Gold Discovers Significant Gold System at Lizard Pond Claims – Gander South Project